Cadence Neuroscience Secures $26 Million in Series B Financing for Clinical Trials of Epilepsy Neuromodulation Therapy 5/17/2023 Category: INVESTMENTS
Announcing the CeMM & Angelini Ventures Healthy Lifespan Expansion Initiative 3/23/2023 Category: RESEARCH PARTNERSHIPS
Angelini Ventures hosts the first Demo Day of VITA, the Digital Health Accelerator of CDP Venture Capital's National Accelerator Network 3/1/2023 Category: INNOVATION
Angelini Ventures invests in Serenis to continue scaling accessible and effective mental health care solutions 11/10/2022 Category: DIGITAL HEALTH
Angelini Ventures, Evotec and CDP Venture Capital launch translational partnership ‘Extend’ with leading Italian academic Institutions. 10/28/2022 Category: ACADEMIC PARTNERSHIPS
Pretzel Therapeutics, eyeing diseases caused by broken mitochondria, launches with $72.5 million 10/12/2022 Category: BIOTECH
Angelini Ventures